Add Yahoo as a preferred source to see more of our stories on Google. Galderma has earned another FDA-approval for its popular filler brand Restylane. Monday morning, Galderma announced that its ...
FORT WORTH, Texas, June 29, 2021 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) has approved Restylane ® Contour for cheek augmentation and correction of midface ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma will present a range of new scientific data on its portfolio on their hyaluronic acid dermal filler range, their first liquid neuromodulator and their ...
(MENAFN- AETOSWire) (BUSINESS WIRE ) -- Galderma (SIX: GALD), the pure-play dermatology category leader, has launched 'Wake Up To Restylane', a global campaign that showcases Restylane as an everyday ...
Please provide your email address to receive an email when new articles are posted on . Actress Sharon Stone has partnered with Galderma to launch an international campaign on Restylane products, ...
Launching an aesthetic product during COVID-19 sounds tricky, but Galderma’s looking on the bright side as it rolls out its newly approved Restylane Kysse lip filler. The lip augmentation product got ...
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9158251-galderma-restylane-eyelight-fda-approval/ "Restylane ...
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovations like ...
Please provide your email address to receive an email when new articles are posted on . Restylane Contour has been approved by the FDA for cheek augmentation and the correction of midface contour ...
There are “prevalent societal misconceptions and stereotypes” facing the aesthetics industry that must be addressed, according to a new survey out by Galderma, which markets Restylane, a product that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results